<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33887086</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-7633</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Chembiochem : a European journal of chemical biology</Title><ISOAbbreviation>Chembiochem</ISOAbbreviation></Journal><ArticleTitle>Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity.</ArticleTitle><Pagination><StartPage>2116</StartPage><EndPage>2123</EndPage><MedlinePgn>2116-2123</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cbic.202100038</ELocationID><Abstract><AbstractText>Selinexor, a covalent XPO1 inhibitor, is approved in the USA in combination with dexamethasone for penta-refractory multiple myeloma. Additional XPO1 covalent inhibitors are currently in clinical trials for multiple diseases including hematologic malignancies, solid tumor malignancies, glioblastoma multiforme (GBM), and amyotrophic lateral sclerosis (ALS). It is important to measure the target engagement and selectivity of covalent inhibitors to understand the degree of engagement needed for efficacy, while avoiding both mechanism-based and off-target toxicity. Herein, we report clickable probes based on the XPO1 inhibitors selinexor and eltanexor for the labeling of XPO1 in live cells to assess target engagement and selectivity. We used mass spectrometry-based chemoproteomic workflows to profile the proteome-wide selectivity of selinexor and eltanexor and show that they are highly selective for XPO1. Thermal profiling analysis of selinexor further offers an orthogonal approach to measure XPO1 engagement in live cells. We believe these probes and assays will serve as useful tools to further interrogate the biology of XPO1 and its inhibition in cellular and in&#x2005;vivo systems.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley-VCH GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0002-5809-691X</Identifier><AffiliationInfo><Affiliation>Biogen, Chemical Biology &amp; Proteomics 225 Binney Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-8735-5263</Identifier><AffiliationInfo><Affiliation>Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feyertag</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biogen, Chemical Biology &amp; Proteomics 225 Binney Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couvertier</LastName><ForeName>Shalise</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biogen, Chemical Biology &amp; Proteomics 225 Binney Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guckian</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Biogen, Medicinal Chemistry 225 Binney Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>Kilian V M</ForeName><Initials>KVM</Initials><Identifier Source="ORCID">0000-0002-1103-5300</Identifier><AffiliationInfo><Affiliation>Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Douglas S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0003-2703-6495</Identifier><AffiliationInfo><Affiliation>Biogen, Chemical Biology &amp; Proteomics 225 Binney Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>875510</GrantID><Agency>Innovative Medicines Initiative 2 Joint Undertaking (JU)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Chembiochem</MedlineTA><NlmUniqueID>100937360</NlmUniqueID><ISSNLinking>1439-4227</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006834">Hydrazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028884">Karyopherins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014230">Triazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078342">exportin 1 protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>31TZ62FO8F</RegistryNumber><NameOfSubstance UI="C585161">selinexor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005909" MajorTopicYN="N">Glioblastoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006834" MajorTopicYN="N">Hydrazines</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028884" MajorTopicYN="N">Karyopherins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014230" MajorTopicYN="N">Triazoles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">XPO1 inhibitors</Keyword><Keyword MajorTopicYN="N">chemical proteomics</Keyword><Keyword MajorTopicYN="N">clickable probes</Keyword><Keyword MajorTopicYN="N">target engagement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>17</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33887086</ArticleId><ArticleId IdType="doi">10.1002/cbic.202100038</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>S. C. Fu, H. C. Huang, P. Horton, H. F. Juan, Nucleic Acids Res. 2013, 41, 338-343.</Citation></Reference><Reference><Citation>D. Xu, N. V. Grishin, Y. M. Chook, Mol. Biol. Cell 2012, 23, 3673-3676.</Citation></Reference><Reference><Citation>A. Y. Wang, H. Liu, Stem Cell Investig. 2019, 6, 6.</Citation></Reference><Reference><Citation>J. Taylor, M. Sendino, A. N. Gorelick, A. Pastore, M. T. Chang, A. V. Penson, E. I. Gavrila, C. Stewart, E. M. Melnik, F. Herrejon Chavez, L. Bitner, A. Yoshimi, S. C.-W. Lee, D. Inoue, B. Liu, X. J. Zhang, A. R. Mato, A. Dogan, M. G. Kharas, Y. Chen, D. Wang, R. K. Soni, R. C. Hendrickson, G. Prieto, J. A. Rodriguez, B. S. Taylor, O. Abdel-Wahab, Cancer Discovery 2019, 9, 1452.</Citation></Reference><Reference><Citation>U. H. Gandhi, W. Senapedis, E. Baloglu, T. J. Unger, A. Chari, D. Vogl, R. F. Cornell, Clin. Lymph. Myel. Leuk. 2018, 18, 335-345.</Citation></Reference><Reference><Citation>H. C. Archbold, K. L. Jackson, A. Arora, K. Weskamp, E. M. Tank, X. Li, R. Miguez, R. D. Dayton, S. Tamir, R. L. Klein, S. J. Barmada, Sci. Rep. 2018, 8, 4606.</Citation></Reference><Reference><Citation>M. J. Silvestrini, J. R. Johnson, A. V. Kumar, T. G. Thakurta, K. Blais, Z. A. Neill, S. W. Marion, V. St Amand, R. A. Reenan, L. R. Lapierre, Cell Rep. 2018, 23, 1915-1921.</Citation></Reference><Reference><Citation>J. Steyaert, W. Scheveneels, J. Vanneste, P. Van Damme, W. Robberecht, P. Callaerts, E. Bogaert, L. Van Den Bosch, Hum. Mol. Genet. 2018, 27, 4103-4116.</Citation></Reference><Reference><Citation>T. Vercruysse, J. De Bie, J. E. Neggers, M. Jacquemyn, E. Vanstreels, J. L. Schmid-Burgk, V. Hornung, E. Baloglu, Y. Landesman, W. Senapedis, S. Shacham, A. Dagklis, J. Cools, D. Daelemans, Clin. Cancer Res. 2017, 23, 2528-2541.</Citation></Reference><Reference><Citation>M. L. Crochiere, E. Baloglu, B. Klebanov, S. Donovan, D. Del Alamo, M. Lee, M. Kauffman, S. Shacham, Y. Landesman, Oncotarget 2016, 7, 1863-1877.</Citation></Reference><Reference><Citation>J. Etchin, T. Sanda, M. R. Mansour, A. Kentsis, J. Montero, B. T. Le, A. L. Christie, D. McCauley, S. J. Rodig, M. Kauffman, S. Shacham, R. Stone, A. Letai, A. L. Kung, A. Thomas Look, Brit. J. Haematol. 2013, 161, 117-127.</Citation></Reference><Reference><Citation>J. Etchin, Q. Sun, A. Kentsis, A. Farmer, Z. C. Zhang, T. Sanda, M. R. Mansour, C. Barcelo, D. McCauley, M. Kauffman, S. Shacham, A. L. Christie, A. L. Kung, S. J. Rodig, Y. M. Chook, A. T. Look, Leukemia 2013, 27, 66-74.</Citation></Reference><Reference><Citation>R. Lapalombella, Q. Sun, K. Williams, L. Tangeman, S. Jha, Y. Zhong, V. Goettl, E. Mahoney, C. Berglund, S. Gupta, A. Farmer, R. Mani, A. J. Johnson, D. Lucas, X. Mo, D. Daelemans, V. Sandanayaka, S. Shechter, D. McCauley, S. Shacham, M. Kauffman, Y. M. Chook, J. C. Byrd, Blood 2012, 120, 4621-34.</Citation></Reference><Reference><Citation>J. E. Neggers, E. Vanstreels, E. Baloglu, S. Shacham, Y. Landesman, D. Daelemans, Oncotarget 2016, 7, 68842-68850.</Citation></Reference><Reference><Citation>K. M. Backus, B. E. Correia, K. M. Lum, S. Forli, B. D. Horning, G. E. Gonz&#xe1;lez-P&#xe1;ez, S. Chatterjee, B. R. Lanning, J. R. Teijaro, A. J. Olson, D. W. Wolan, B. F. Cravatt, Nature 2016, 534, 570-4.</Citation></Reference><Reference><Citation>D. S. Johnson, E. Weerapana, B. F. Cravatt, Fut. Med. Chem. 2010, 2, 949-64.</Citation></Reference><Reference><Citation>A. Lin, C. J. Giuliano, A. Palladino, K. M. John, C. Abramowicz, M. L. Yuan, E. L. Sausville, D. A. Lukow, L. Liu, A. R. Chait, Z. C. Galluzzo, C. Tucker, J. M. Sheltzer, Sci. Transl. Med. 2019, 11, eaaw8412.</Citation></Reference><Reference><Citation>J. A. Ward, L. McLellan, M. Stockley, K. R. Gibson, G. A. Whitlock, C. Knights, J. A. Harrigan, X. Jacq, E. W. Tate, ACS Chem. Biol. 2016, 11, 3268-3272.</Citation></Reference><Reference><Citation>J. A. Ward, A. Pinto-Fernandez, L. Cornelissen, S. Bonham, L. D&#xed;az-S&#xe1;ez, O. Riant, K. V. M. Huber, B. M. Kessler, O. Feron, E. W. Tate, J. Med. Chem. 2020, 63, 3756-3762.</Citation></Reference><Reference><Citation>M. J. Niphakis, B. F. Cravatt, Ann. Rev. Biochem. 2014, 83, 341-377.</Citation></Reference><Reference><Citation>D. S. Johnson, J. D. Majmudar, Cell Chem. Biol. 2017, 24, 1317-1318.</Citation></Reference><Reference><Citation>H. Xu, M. I. Jesson, U. I. Seneviratne, T. H. Lin, M. N. Sharif, L. Xue, C. Nguyen, R. A. Everley, J. I. Trujillo, D. S. Johnson, G. R. Point, A. Thorarensen, I. Kilty, J. B. Telliez, ACS Chem. Biol. 2019, 14, 1235-1242.</Citation></Reference><Reference><Citation>K. Ahn, S. E. Smith, M. B. Liimatta, D. Beidler, N. Sadagopan, D. T. Dudley, T. Young, P. Wren, Y. Zhang, S. Swaney, K. Van Becelaere, J. L. Blankman, D. K. Nomura, S. N. Bhattachar, C. Stiff, T. K. Nomanbhoy, E. Weerapana, D. S. Johnson, B. F. Cravatt, J. Pharmacol. Exp. Ther. 2011, 338, 114-24.</Citation></Reference><Reference><Citation>B. R. Lanning, L. R. Whitby, M. M. Dix, J. Douhan, A. M. Gilbert, E. C. Hett, T. O. Johnson, C. Joslyn, J. C. Kath, S. Niessen, L. R. Roberts, M. E. Schnute, C. Wang, J. J. Hulce, B. Wei, L. O. Whiteley, M. M. Hayward, B. F. Cravatt, Nat. Chem. Biol. 2014, 10, 760-767.</Citation></Reference><Reference><Citation>D. K. Nomura, T. J. Maimone, Curr. Top. Microbiol. Immunol. 2019, 420, 351-374.</Citation></Reference><Reference><Citation>M. Gehringer, S. A. Laufer, J. Med. Chem. 2019, 62, 5673-5724.</Citation></Reference><Reference><Citation>T. Zhang, J. M. Hatcher, M. Teng, N. S. Gray, M. Kostic, Cell Chem. Biol. 2019, 26, 1486-1500.</Citation></Reference><Reference><Citation>M. Abo, C. Li, E. Weerapana, Mol. Pharm. 2018, 15, 743-749.</Citation></Reference><Reference><Citation>E. Weerapana, C. Wang, G. M. Simon, F. Richter, S. Khare, M. B. D. Dillon, D. A. Bachovchin, K. Mowen, D. Baker, B. F. Cravatt, Nature 2010, 468, 790-795.</Citation></Reference><Reference><Citation>M. M. Savitski, F. B. M. Reinhard, H. Franken, T. Werner, M. F. Savitski, D. Eberhard, D. M. Molina, R. Jafari, R. B. Dovega, S. Klaeger, B. Kuster, P. Nordlund, M. Bantscheff, G. Drewes, Science 2014, 346, 1255784.</Citation></Reference><Reference><Citation>K. V. M. Huber, K. M. Olek, A. C. M&#xfc;ller, C. S. H. Tan, K. L. Bennett, J. Colinge, G. Superti-Furga, Nat. Meth. 2015, 12, 1055-1057.</Citation></Reference><Reference><Citation>M. Namba, T. Ohtsuki, M. Mori, A. Togawa, H. Wada, T. Sugihara, Y. Yawata, T. Kimoto, In Vitro Cell. Dev. Biol. 1989, 25, 723-729.</Citation></Reference><Reference><Citation>W. F. Lenoir, T. L. Lim, T. Hart, Nucleic Acids Res. 2017, 46, D776-D780.</Citation></Reference><Reference><Citation>H. Xicoy, B. Wieringa, G. J. Martens, Mol. Neurodegener. 2017, 12, 10.</Citation></Reference><Reference><Citation>H. Franken, T. Mathieson, D. Childs, G. M. Sweetman, T. Werner, I. T&#xf6;gel, C. Doce, S. Gade, M. Bantscheff, G. Drewes, F. B. Reinhard, W. Huber, M. M. Savitski, Nat. Protoc. 2015, 10, 1567-93.</Citation></Reference><Reference><Citation>M. M. Savitski, F. B. Reinhard, H. Franken, T. Werner, M. F. Savitski, D. Eberhard, D. Martinez Molina, R. Jafari, R. B. Dovega, S. Klaeger, B. Kuster, P. Nordlund, M. Bantscheff, G. Drewes, Science 2014, 346, 1255784.</Citation></Reference><Reference><Citation>J. E. Neggers, T. Vercruysse, M. Jacquemyn, E. Vanstreels, E. Baloglu, S. Shacham, M. Crochiere, Y. Landesman, D. Daelemans, Chem. Biol. 2015, 22, 107-116.</Citation></Reference><Reference><Citation>Z. A. Hing, H. Y. J. Fung, P. Ranganathan, S. Mitchell, D. El-Gamal, J. A. Woyach, K. Williams, V. M. Goettl, J. Smith, X. Yu, X. Meng, Q. Sun, T. Cagatay, A. M. Lehman, D. M. Lucas, E. Baloglu, S. Shacham, M. G. Kauffman, J. C. Byrd, Y. M. Chook, R. Garzon, R. Lapalombella, Leukemia 2016, 30, 2364-2372.</Citation></Reference><Reference><Citation>J. A. Rodr&#xed;guez, Semin. Cancer Biol. 2014, 27, 11-19.</Citation></Reference><Reference><Citation>C. Ptak, R. W. Wozniak, SUMO and Nucleocytoplasmic Transport, SUMO Regulation of Cellular Processes (Ed.: V.&#x2005;G. Wilson), Springer, Cham, 2017, pp.&#x2005;111-126.</Citation></Reference><Reference><Citation>E. Da Silva-Ferrada, F. Lopitz-Otsoa, V. Lang, M. S. Rodr&#xed;guez, R. Matthiesen, Biochem. Res. Int. 2012, 2012, 875148.</Citation></Reference><Reference><Citation>D. Wen, Z. Xu, L. Xia, X. Liu, Y. Tu, H. Lei, W. Wang, T. Wang, L. Song, C. Ma, H. Xu, W. Zhu, G. Chen, Y. Wu, J. Proteome Res. 2014, 13, 3571-3582.</Citation></Reference><Reference><Citation>R. Bruderer, M. H. Tatham, A. Plechanovova, I. Matic, A. K. Garg, R. T. Hay, EMBO Rep. 2011, 12, 142-148.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>